• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATX

AMPLIA THERAPEUTICS LIMITED

2.94% ! 16.5¢
Market Cap $80.26M  !

Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development... Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development company. The Company is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. The Company's pipeline includes narmafotinib (AMP945) and AMP886. narmafotinib is a selective and potent inhibitor of FAK and is in clinical development for pancreatic cancer and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The Company's second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its fibrosis program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue and therefore block survival/proliferation signals.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATX 00:11 57 10K
00:11 Last post  RapidFortune Comments Created with Sketch.  57  Views Created with Sketch.  10K 
ATX 30/08/25 5 1.3K
30/08/25 Last post  Duke2 Comments Created with Sketch.  5  Views Created with Sketch.  1.3K 
ATX 29/08/25 19 3.6K
29/08/25 Last post  HandDontCount Comments Created with Sketch.  19  Views Created with Sketch.  3.6K 
ATX 29/08/25 0 150
29/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  150 
ATX 27/08/25 0 247
27/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  247 
ATX
ATX - General discussion
6 7 8
26/08/25 436 140K
26/08/25 Last post  Eclectic_nish Comments Created with Sketch.  436  Views Created with Sketch.  140K 
ATX
ATX in the US under INNMF.
22/08/25 3 1.1K
22/08/25 Last post  Burge13 Comments Created with Sketch.  3  Views Created with Sketch.  1.1K 
ATX 16/08/25 185 57K
16/08/25 Last post  suhm Comments Created with Sketch.  185  Views Created with Sketch.  57K 

See All Discussions arrow Created with Sketch.

Timeline

AUSTRALIAN TRIAL SITES OPEN FOR NEW NARMAFOTINIB TRIAL
29 Aug 08:24
 
Application for quotation of securities - ATX
29 Aug 08:16
 
Results of Annual General Meeting
27 Aug 11:58
 
Managing Director's Presentation to AGM
27 Aug 10:08
 
Amplia Share Purchase Plan Raises $2.65 Million
26 Aug 09:12
 
Presentation - Targeting Pancreatic Cancer and Beyond
07 Aug 09:34
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
16.5¢
Change
-0.005(2.94%)
Mkt cap ! $80.26M
Open High Low Value Volume
17.0¢ 17.5¢ 16.3¢ $701.7K 4.156M

Buyers (Bids)

No. Vol. Price($)
1 24928 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 89726 4
View Market Depth
Last trade - 16.10pm 29/08/2025 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.